Document is current
Any future updates will be listed below
-
Authors
Bousquets-Muñoz, Pablo https://orcid.org/0000-0002-2969-008X
Molina, Oscar https://orcid.org/0000-0001-7585-4519
Varela, Ignacio https://orcid.org/0000-0002-0969-506X
Álvarez-Eguiluz, Ángel
Fernández-Mateos, Javier
Gómez, Ana
Sánchez, Elena G.
Balbín, Milagros
Ruano, David
Ramírez-Orellana, Manuel https://orcid.org/0000-0003-0332-6973
Puente, Xose S. https://orcid.org/0000-0001-9525-1483
Menéndez, Pablo
Velasco-Hernandez, Talia https://orcid.org/0000-0003-2183-7443
-
Funding
Funding for this research was provided by:
Ministerio de Economía y Competitividad (PID2020-117185RB-I00)
Ministry of Economy and Competitiveness | Secretaría de Estado de Investigación, Desarrollo e Innovación (PID2022-142966OB-I00)
- License Information
-
More Information
Article History
Received: 26 February 2024
Revised: 15 May 2024
Accepted: 17 May 2024
First Online: 28 May 2024
Competing interests
: PM is the founder of the spin-off OneChain Immunotherapeutics which has no connection with the present research. The remaining authors declare no competing interests.
